DefendMe Suite
DefendMe | Immune Resilience Restored
You used to get sick less. Recover faster. Shake things off and keep moving. Somewhere along the way that changed. Your immune system isn’t weak – it may simply be dysregulated. Thymosin Alpha-1 is an immune-modulating peptide. It has been tested mainly in people with infections such as hepatitis B and C or sepsis, rather than in healthy adults.1
Not Weak. Dysregulated. There’s a Difference.
Your immune system is constantly working – identifying threats, managing inflammation, and repairing damage. But immune function isn’t static. The thymus gland, which trains your T cells, gradually shrinks from early life onward and produces fewer new T cells with age – a process called age-related thymic involution.2
Not always as dramatic illness. Sometimes it’s the low-grade heaviness that never fully lifts. The chronic inflammatory burden that drains energy, clouds thinking, and makes recovery from everything slower than it should be. The sense that your body is always fighting something it can never quite resolve.
Thymosin Alpha-1 is a peptide originally isolated from thymus tissue. Given by subcutaneous injection, it acts on immune cells through Toll-like receptors on dendritic cells, and researchers describe it as a regulator of immunity, tolerance and inflammation.34
In research it has been described as both an immune enhancer and a regulator of inflammation, and individual response varies.
What Our Patients Notice With Thymosin Alpha-1
What patients typically report
Individual experiences vary, and the reports below are patient observations rather than results from clinical trials. Here’s what patients commonly report.
I’m not getting taken down by every illness anymore.
Fewer sick days, faster recovery when illness does occur, and a sense that the body is responding appropriately from the start rather than getting behind and struggling to catch up.
The low-grade heaviness is finally lifting.
Chronic, subclinical inflammation is one of the most common things patients describe – a background drain on energy, cognitive clarity, and physical resilience. Whether Thymosin Alpha-1 reduces low-grade inflammation in otherwise healthy adults has not yet been established in clinical trials.
I feel genuinely resilient – not just less sick.
There’s a difference between an immune system that is constantly reactive and one that is truly stable. Patients describe a qualitative shift – steadier, more responsive, not burning resources on threats that have already passed.
I recover from everything faster – not just illness.
Training, stress, travel, demanding seasons – all of it taxes immune function. As that foundation improves, patients notice faster bounce-back across the board, not just from acute illness.
My chronic condition feels more manageable.
Thymosin Alpha-1 has been studied mostly in chronic infections such as hepatitis B, where a Cochrane review judged the certainty of the evidence to be low or very low; evidence in autoimmune conditions is limited, so your provider will weigh it against your history.5
A long-term view of immune health.
Immune resilience is not just about avoiding illness. It is about maintaining the biological environment that supports every other aspect of your health – hormone function, peptide response, metabolic health, and longevity.
Does This Sound Like You?
DefendMe tends to be a strong fit for men and women who notice their immune system is no longer responding the way it used to – and who want to address that proactively, not reactively.
You may be a good candidate if you:
- Get sick more often than you used to, or take longer to fully recover
- Carry a persistent sense of inflammation, fatigue, or immune burden that never fully resolves
- Are managing a chronic illness, autoimmune condition, or history of frequent infections
- Are going through or recovering from a period of prolonged stress, surgery, or illness
- Travel frequently or work in high-exposure environments
- Want to proactively protect long-term immune health as part of a comprehensive longevity plan
Our provider team will evaluate your immune markers, inflammatory status, and full health picture before any protocol is recommended. Nothing is prescribed without a complete clinical assessment.
Our Foundational Assessment is where it starts. It gives us – and you – everything we need.
How is Thymosin Alpha-1 different from immune supplements or boosters?
Most immune supplements either broadly stimulate the immune system or provide general nutritional support. Thymosin Alpha-1 is a prescription peptide that acts on immune signaling – including Toll-like receptors on dendritic cells – and has been described as a regulator of immunity, tolerance and inflammation. Most clinical trials have been in people with infections, cancer or weakened immunity rather than in healthy adults.31
How is it administered?
Thymosin Alpha-1 is given via subcutaneous injection – a small, fine-needle injection typically self-administered at home. Our care team provides full training and is available for support throughout your protocol.
What is the difference between the Seasonal and Ongoing protocols?
The Seasonal protocol (one cycle, usually about 1 month, with benefits that can last up to 2 months) is designed for patients who want targeted immune support heading into high-risk periods – flu season, travel, periods of high stress or immune demand. The Ongoing protocol provides continuous immune regulation for patients managing chronic inflammatory conditions, frequent illness, or who want immune resilience as a foundational part of their long-term health plan. Our provider team will help determine which approach fits your picture.
Can it be used with autoimmune conditions?
It may be considered, but the evidence here is still early. People with psoriatic arthritis, rheumatoid arthritis and lupus have been found to have lower blood levels of thymosin alpha-1 than healthy controls, while controlled treatment trials in these conditions are limited.6 Your provider will review your specific condition and history before recommending a protocol.
Is it safe?
Thymosin Alpha-1 has been tested in many clinical trials, mainly in people with infections such as hepatitis B and C or sepsis, and it has generally been well tolerated in those studies, including a 1,100-patient placebo-controlled sepsis trial in which no safety outcome differed from placebo.17 At YoungerMeMD, it is never prescribed without a full evaluation and ongoing monitoring by our provider team.
Can it be combined with other protocols?
Yes. Thymosin Alpha-1 integrates naturally alongside hormone optimization, growth hormone peptides, healing peptides, and longevity protocols. Combinations with other peptide or hormone protocols have not yet been studied in clinical trials, so your provider decides what is appropriate case by case. Every protocol is built individually by our provider team.
Is this covered by insurance?
DefendMe is offered through YoungerMeMD’s membership-based model, which operates outside of traditional insurance. Your membership includes physician oversight, ongoing protocol management, and the kind of personalized attention that insurance-based care isn’t designed to provide.
What is the difference between a weak and a dysregulated immune system?
A dysregulated immune system is not necessarily weak; it is out of balance. It may show up as low-grade heaviness, chronic inflammatory burden, and slower recovery rather than dramatic illness.
How does Thymosin Alpha-1 work?
Why does immune function change with age?
The thymus gland, which trains immune (T) cells, gradually shrinks from early life onward, so fewer new T cells are produced as you age – a process called age-related thymic involution.2
Questions We Hear All the Time
Safety & Considerations
Thymosin Alpha-1 is generally very well tolerated. Some patients may notice mild injection site irritation or brief flu-like symptoms during early use. These effects are typically mild and self-limited.
Thymosin Alpha-1 should be used with caution in patients who have received solid organ transplants. Always inform your provider about all current medications, supplements, and existing immune or inflammatory conditions before starting any protocol.
Clinical response is enhanced when supported by restorative sleep, stress management, regular physical activity, and balanced nutrition – all of which directly influence immune regulation.
Pharmaceutical-Grade. Every Time.
Every Thymosin Alpha-1 prescription at YoungerMeMD is sourced exclusively from fully vetted, state-licensed 503A compounding pharmacies. Our peptides are never labeled “for research purposes.” They are compounded for prescription clinical use only – dispensed under physician supervision, prepared to strict standards for sterility, potency, and quality control.
Your immune system deserves pharmaceutical-grade precision. That is the only standard we use.
The YoungerMeMD DefendMe Program
Designed to regulate, restore, and build lasting immune resilience.
Foundational Assessment
$599
A complete assessment of:
- Immune health markers and inflammatory status
- History of illness frequency, recovery patterns, and chronic conditions
- Autoimmune history and current immune load
- Metabolic factors contributing to immune dysregulation
- Current medications, supplements, and contraindications
This establishes the right DefendMe protocol for your picture – Seasonal, Ongoing, or in combination with other suite programs.
Peptide Membership
$279/month
Your foundational membership provides continuous support and medical oversight.
Your Membership Includes:
- Personalized peptide programming
- Ongoing biological and functional monitoring
- Direct clinician messaging
- Protocol optimization based on response
- Exclusive pricing on peptide cycles
DefendMe Treatment Plan
$199/month
Two protocol options based on your clinical picture and goals:
Seasonal Protocol – $199/month
One cycle, usually about 1 month, with benefits that can last up to 2 months. Targeted immune support during high-risk periods – flu season, travel, periods of high stress or elevated immune demand.
Ongoing Protocol – $199/month
Continuous immune regulation for patients managing chronic inflammatory conditions, autoimmune history, or who want immune resilience as a foundational part of their long-term health plan.
Your provider team will determine which protocol is the right fit based on your assessment findings and goals.
Pairs Well With DefendMe
A well-regulated immune system is the foundation that makes every other protocol work better. DefendMe is frequently combined with these programs for patients whose goals extend beyond immune health alone — or whose underlying biology needs support at more than one level.
RenewMe — GHK-Cu
Chronic low-grade inflammation is thought to contribute to skin aging and slower tissue repair. DefendMe focuses on immune regulation, while GHK-Cu is studied for skin and tissue renewal. The combination itself has not yet been tested in clinical trials.
Best for: patients with inflammatory history alongside skin thinning, hair changes, or slow tissue healing
Learn about RenewMeHealing Peptides — BPC-157
BPC-157 has shown tissue-repair effects in animal studies, but these findings have not yet been validated in human trials. However, anecdotally, positive patient outcomes are noted. Thymosin Alpha-1 is an immune-modulating peptide; whether it speeds healing after injury or surgery, alone or with BPC-157, has not yet been studied.8 For patients dealing with injury, post-surgical recovery, or chronic pain, the combination addresses both the repair signal and the systemic environment it requires.
Best for: patients recovering from injury, surgery, or chronic musculoskeletal conditions alongside immune burden
Learn about Healing PeptidesHormone Optimization
Sex hormones influence immune function, and hormone levels change with age. DefendMe focuses on immune regulation while hormone therapy addresses hormone levels; whether combining them improves results has not yet been studied in clinical trials.
Best for: patients 40 and over whose immune decline has a hormonal component, or who are in perimenopause or andropause
Learn about Hormone HealthPeak Performance — GH Peptides
Growth hormone signaling and the immune system interact in several ways. Whether adding Thymosin Alpha-1 changes the response to growth hormone peptides has not yet been studied. Patients serious about long-term performance and longevity frequently run both as part of a comprehensive protocol.
Best for: performance-focused patients whose inflammatory load or immune burden is limiting results from GH optimization
Learn about Peak PerformanceYour Immune System Has Always Protected You. Now It’s Your Turn.
Genuine immune resilience isn’t about avoiding every illness. It’s about a body that responds intelligently, recovers completely, and stays capable of protecting everything you’ve built.
DefendMe is one of the most targeted tools we have for patients whose immune system needs more than maintenance. And it starts with the right clinical picture.
Book a Peptide Consult and let’s look at what your immune markers are telling us. From there, our provider team will build a protocol that fits your health, your goals, and your life.
References
- Camerini R, Garaci E. Historical review of thymosin α 1 in infectious diseases. Expert Opin Biol Ther 2015. PMID 26098768 · doi:10.1517/14712598.2015.1033393↩
- Liang Z, et al. Age-related thymic involution: Mechanisms and functional impact. Aging Cell 2022. PMID 35822239 · PMC9381902 · doi:10.1111/acel.13671↩
- King R, Tuthill C. Immune Modulation with Thymosin Alpha 1 Treatment. Vitam Horm 2016. PMID 27450734 · doi:10.1016/bs.vh.2016.04.003↩
- Pica F, et al. Serum thymosin alpha 1 levels in normal and pathological conditions. Expert Opin Biol Ther 2018. PMID 30063864 · doi:10.1080/14712598.2018.1474197↩
- Naing C, et al. Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database Syst Rev 2026. PMID 42713852 · PMC13555770 · doi:10.1002/14651858.CD014610.pub2↩
- Pica F, et al. Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases. Clin Exp Immunol 2016. PMID 27350088 · PMC5011367 · doi:10.1111/cei.12833↩
- Wu J, et al. The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial. BMJ 2025. PMID 39814420 · PMC11780596 · doi:10.1136/bmj-2024-082583↩
- Mayfield CK, et al. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. Am J Sports Med 2026. PMID 41476424 · doi:10.1177/03635465251357593↩